Implantable Cardiac Electronic Devices

  • Michael L. HallEmail author
  • G. Alec Rooke


Patients with pacemakers or internal cardioverter-defibrillators (ICDs) are at risk for device malfunction or exposure to electromagnetic interference (EMI) from monopolar cautery, magnetic resonance imaging (MRI), radiofrequency ablation, electroconvulsive therapy, lithotripsy, and therapeutic radiation. The most common and potentially life-threatening adverse effects of EMI are inhibition of cardiac pacing (leading to bradycardia or asystole) and inadvertent shocks if an ICD interprets the EMI as a heart rate above the therapy trigger rate. Most experts recommend that a plan for device management for surgery be made by a qualified individual, and that the recommendation be based on knowledge of the proposed surgery and the information gleaned from a recent interrogation of the device. Technological advancement with subcutaneous ICDs and leadless pacemakers has demonstrated the need for continuous education for those taking care of implantable cardiac devices in perioperative period.


Cardiac implantable electronic device CIED Pacemaker Implantable cardioverter defibrillator Perioperative management 


  1. 1.
    Gold MR, Aasbo JD, El-Chami MF, Niebauer M, Herre J, Prutkin JM, Knight BP, Kutalek S, Hsu K, Weiss R, Bass E, Husby M, Stivland TM, Burke MC. Subcutaneous implantable cardioverter-defibrillator post-approval study: clinical characteristics and perioperative results. Heart Rhythm. 2017;14(10):1456–63. Open image in new windowCrossRefGoogle Scholar
  2. 2.
    Chang PM, Doshi R, Saxon LA. Subcutaneous implantable cardioverter-defibrillator. Circulation. 2014;129(23):e644–46. Open image in new windowGoogle Scholar
  3. 3.
    Mickus GJ, Soliman GI, Reed RR, Martin AK. Perioperative management of a leadless pacemaker_ the paucity of evidence-based guidelines. J Cardiothorac Vasc Anesth. 2016;30(6):1594–8.CrossRefGoogle Scholar
  4. 4.
    Crossley GH, Poole JE, Rozner MA, Asirvatham SJ, Cheng A, Chung MK, Ferguson Jr TB, Gallagher JD, Gold MR, Hoyt RH, Irefin S, Kusumoto FM, Moorman LP, Thompson A. The Heart Rhythm Society expert consensus statement on the perioperative management of patients with implantable defibrillators, pacemakers and arrhythmia monitors: facilities and patient management. Heart Rhythm. 2011;8:1114. Open image in new windowCrossRefGoogle Scholar
  5. 5.
    Allen M. Pacemakers and implantable cardioverter defibrillators. Anaesthesia. 2006;61:883–90.CrossRefGoogle Scholar
  6. 6.
    Moses HW, Mullin JC. A practical guide to cardiac pacing. 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2007. ISBN 978-0-7817-8881-6.Google Scholar
  7. 7.
    Bernstein AD, Daubert JC, Fletcher RD, et al. The revised NASPE/BPEG generic code for antibradycardia, adaptive-rate, and multisite pacing. Pacing Clin Electrophysiol. 2002;25:260–4.CrossRefGoogle Scholar
  8. 8.
    Leung S-K, Lau C-P. Developments in sensor-driven pacing. Cardiol Clin. 2000;18:113–55.CrossRefGoogle Scholar
  9. 9.
    Gallagher MD, David Hayes MD, Jane EH. ASA task force on perioperative management of patients with cardiac implantable electronic devices. Practice advisory for the perioperative management of patients with cardiac implantable electronic devices: pacemakers and implantable cardioverter-defibrillators. Anesthesiology. 2011;114:247–61.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.Department of Anesthesiology and Pain MedicineUniversity of Washington School of MedicineSeattleUSA

Personalised recommendations